Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05 2024 - 3:02PM
Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a
mission to protect the vulnerable from serious viral infectious
diseases, today announced that David Hering, Chief Executive
Officer of Invivyd, is scheduled to present in a fireside chat at
the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
on Thursday, February 8, 2024 at 1:00 p.m. ET in New York, NY.
In addition to the fireside chat, the management team will host
investor meetings at the conference. Investors participating in the
conference who are interested in meeting with Invivyd management
should contact their Guggenheim representative.
A live webcast of the fireside chat will be available in the
investor section of the company's website at investors.invivyd.com
and will be archived for approximately 30 days following the
presentation.
About InvivydInvivyd, Inc. (Nasdaq: IVVD) is a
biopharmaceutical company on a mission to rapidly and perpetually
deliver antibody-based therapies that protect vulnerable people
from the devastating consequences of circulating viral threats,
beginning with SARS-CoV-2. The company’s proprietary INVYMAB™
platform approach combines state-of-the-art viral surveillance and
predictive modeling with advanced antibody engineering. Leveraging
its INVYMAB platform approach, the company is generating a robust
pipeline of product candidates which could be used in prevention or
treatment of serious viral diseases, starting with COVID-19 and
expanding into influenza and other high-need indications. Visit
https://invivyd.com/ to learn more.
Contacts:
Scott Young(781) 208-1747syoung@invivyd.com
Gabriella Linville-Engler(781) 208-0160gengler@invivyd.com
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From Apr 2024 to May 2024
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From May 2023 to May 2024